Over the past couple of months, Oxford University has been hailed as leading the coronavirus vaccine race and now, in further good news, trials show that their vaccine triggers immune response, and early results also indicate the vaccine is safe, raising hopes it could help end pandemic.
The likelihood of a vaccine to address the global spread of coronavirus have been increased after Oxford University’s experimental version was revealed to be safe and to generate a strong immune response in the people who volunteered to help trial it. Professor Sarah Gilbert, from Oxford’s Jenner Institute, said they were more than happy with the first results, which showed good immunity after a single dose of vaccine. “We’re really pleased that it seems to be behaving just as we thought it would do. We have quite a lot of experience of using this technology to make other vaccines, so we knew what we expected to see, and that’s what we have seen,” she told the Guardian.
The prime minister, Boris Johnson, called the results “very positive news”, adding: “There are no guarantees, we’re not there yet and further trials will be necessary - but this is an important step in the right direction.”
The health secretary, Matt Hancock, said: “Very encouraging news. We have already ordered 100 million doses of this vaccine, should it succeed.”
Oxford University's potential vaccine is now one of several in advanced testing, including USA, China and Russia, allowing an optimistic view that one will be successfully made available in the not too distant future. Possibly this year but, more likely, next year.